Summary
The U.S. Army Medical Research Acquisition Activity (USAMRAA), under the Department of Defense, is funding research through the Amyotrophic Lateral Sclerosis (ALS) Research Program's Therapeutic Development Award mechanism. This grant is aimed at advancing therapeutic development for ALS, a progressive neurodegenerative disease. The opportunity is posted on Grants.gov and is open for submissions from May 2026 through September 2026. Full programmatic details, eligibility, and requirements would be contained in the associated Program Announcement or Funding Opportunity Announcement (FOA).